The New York Times
A Promising Heart Drug Failed. What Went So Wrong?
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
View original source — The New York Times ↗
Related stories
The New York Times
BusinessSep 4, 2026 · 1 min
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
The New York Times
MarketWatch
BusinessSep 8, 2026 · 1 min
Novartis’s failed trial for cholesterol drug leads to broad biopharma selloff
MarketWatch
Nature
TechnologySep 9, 2026 · 1 min
A good drug is useless if it misses its target
Nature
Bloomberg
BusinessSep 8, 2026 · 1 min
Novartis Sees Avidity Drug Suffer Third Clinical-Trial Setback
Bloomberg